An Ebola vaccine and drugs to treat the disease would probably have already been discovered if medical research funding had not suffered a series of budget cuts, a top US health official has said.
Francis Collins, the head of the National Institutes of Health, said that agency had been working on Ebola vaccines since 2001, but that the research has been held up by spending cuts.
Of course no bureaucracy would let an opportunity to complain about its budget go to waste.
NiH gets some $30 billion a year. Within that an Ebola vaccine, and any number of treatments, could have been funded. The reality isn’t that cuts stopped them doing so. It was their own internal allocation of funds that stopped them doing so. Ebola was, until very recently, some thing that occasionally killed a few black foreign people in remote villages. Thus rather less was spent on it than, say, the social and cultural understandings of gender.